A multicenter prospective randomized trial of corticosteroids in primary therapy for Kawasaki disease: Clinical course and coronary artery outcome

Journal of Pediatrics

Volumn 149, Issue 3, 2006, Pages

  Inoue, Yoshinari ^a   Okada, Yasunori ^a   Shinohara, Makoto ^a   Kobayashi, Tohru ^a   Kobayashi, Tomio ^a   Tomomasa, Takeshi ^a   Takeuchi, Kazuo ^a   Morikawa, Akihiro ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; C REACTIVE PROTEIN; CORTICOSTEROID; DIPYRIDAMOLE; IMMUNOGLOBULIN; KENKETSU VENILONE I; PREDNISOLONE SODIUM SUCCINATE;

ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY DISEASE; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; ECHOCARDIOGRAPHY; FEMALE; FEVER; GASTROENTERITIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SHOCK; TREATMENT FAILURE; TREATMENT OUTCOME; URINARY TRACT INFECTION;

EID: 33747875063     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2006.05.025     Document Type: Article

References (31)

1. Kawasaki T., Kosaki F., Okawa S., Shigematsu I., and Yanagawa H. A new infantile acute febrile mucocutaneous lymph node syndrome (MCLS) prevailing in Japan. Pediatrics 54 (1974) 271-276
2. Yanagawa H., Nakamura Y., and Yashiro M. The results of 15th nationwide survey of Kawasaki disease in Japan. J Pediatr Practice 63 (2000) 121-132 (in Japanese)
3. Furusho K., Kamiya T., Nakano H., Kiyosawa N., Shinomiya K., Hayashidera T., et al. High-dose intravenous gammaglobulin for Kawasaki disease. Lancet 2 (1984) 1055-1058
4. Newburger J.W., Takahashi M., Beiser A.S., Burns J.C., Bastian J., Chung K.J., et al. Single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 324 (1991) 1633-1639
5. Newburger J.W., Takahashi M., Burns J.C., Beiser A.S., Chung K.J., Duffy C.E., et al. Treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 315 (1986) 341-347
6. Wallace C.A., French J.W., Kahn S.J., and Sherry D.D. Initial intravenous gamma globulin treatment failure in Kawasaki disease. Pediatrics 105 (2000) e78
7. Burns J.C., Capparelli E.V., Brown J.A., Newburger J.W., and Glode M.P. Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. Pediatr Infect Dis J 17 (1998) 1144-1148
8. Han R.K., Silverman E.D., Newman A., and McCrindle B.W. Management and outcome of persistent or recurrent fever after initial intravenous gamma globulin therapy in acute Kawasaki disease. Arch Pediatr Adolesc Med 154 (2000) 694-699
9. Durongpisitkul K., Soongswang J., Laohaprasitiporn D., Nana A., Prachuabmoh C., and Kangkagate C. Immunoglobulin failure and retreatment in Kawasaki disease. Pediatr Cardiol 24 (2003) 145-148
10. Durongpisitkul K., Gururaj V.J., Paark J.M., and Martin C.F. The prevention of coronary artery aneurysm in Kawasaki disease. a meta-analysis on the efficacy of aspirin and immunoglobulin treatment. Pediatrics 96 (1995) 1057-1061
11. Zaitsu M., Hamasaki Y., Tashiro K., Matsuo M., Ichimaru T., Fujita I., et al. Ulinastatin, an elastase inhibitor, inhibits the increased mRNA expression of prostaglandin H2 synthase-type 2 in Kawasaki disease. J Infect Dis 181 (2000) 1101-1109
12. Weiss J.E., Eberhard B.A., Chowdhury D., and Gottlieb B.S. Infliximab as a novel therapy for refractory Kawasaki disease. J Rheumatol 31 (2004) 808-810
13. Shinohara M., Sone K., Tomomasa T., and Morikawa A. Corticosteroids in the treatment of the acute phase of Kawasaki disease. J Pediatr 135 (1999) 411-413
14. Jibiki T., Terai M., Kurosaki T., Nakajima H., Suzuki K., Inomata H., et al. Efficacy of intravenous immune globulin therapy combined with dexamethasone for the initial treatment of acute Kawasaki disease. Eur J Pediatr 163 (2004) 229-233
15. Sundel R.P., Baker A.L., Fulton D.R., and Newberger J.W. Corticosteroids in the initial treatment of Kawasaki disease. report of a randomized trial. J Pediatr 142 (2003) 611-616
16. Kato H., Koike S., and Yokoyama T. Kawasaki disease. effect of treatment on coronary artery involvement. Pediatrics 63 (1979) 175-179
17. Shulman S.T., and Rowley A.H. Advances in Kawasaki disease. Eur J Pediatr 163 (2004) 285-291
18. Dale R.C., Saleem M.A., Daw S., and Dillon M.J. Treatment of severe complicated Kawasaki disease with oral prednisolone and aspirin. J Pediatr 137 (2000) 723-726
19. Harada K. Intravenous gamma-globulin treatment in Kawasaki disease. Acta Paediatr Jpn 33 (1991) 805-810
20. Yanagawa H., Yashiro M., Nakamura Y., Kawasaki T., and Kato H. Epidemiologic pictures of Kawasaki disease in Japan from the nationwide incidence survey in 1991 and 1992. Pediatrics 95 (1995) 475-479
21. Research Committee on Kawasaki Disease. Report of the Subcommittee on Standardization of Diagnostic Criteria and Reporting of Coronary Artery Lesions in Kawasaki Disease. (1984), Ministry of Health and Welfare, Tokyo
22. th ed (1996), WB Saunders, Philadelphia
23. Lin C.Y., Lin C.C., Hwang B., and Chiang B.N. Cytokines predict coronary aneurysm formation in Kawasaki disease patients. Eur J Pediatr 152 (1993) 309-312
24. Matsubara T., Furukawa S., and Yabuta K. Serum levels of tumor necrosis factor, interleukin-2 receptor, and interferon-gamma in Kawasaki disease involved coronary artery lesions. Clin Immunol Immunopathol 56 (1990) 29-36
25. Lin C.Y., Lin C.C., Hwang B., and Chiang B.N. The changes of interleukin-2, tumour necrotic factor and gamma-interferon production among patients with Kawasaki disease. Eur J Pediatr 150 (1991) 179-182
26. Lin C.Y., Lin C.C., Hwang B., and Chiang B. Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease. J Pediatr 121 (1992) 924-926
27. Okada Y., Shinohara M., Kobayashi T., Inoue Y., Tomomasa T., Kobayashi T., et al. Effect of corticosteroids in addition to intravenous gamma globulin therapy on serum cytokine levels in the acute phase of Kawasaki disease in children. J Pediatr 143 (2003) 363-367
28. Streck W.F., and Lockwood D.H. Pituitary recovery following short-term suppression with corticosteroids. Am J Med 66 (1979) 910-914
29. Wilmsmeyer W., Ukena D., Wagner T.O., and Sybrecht G.W. First-time treatment with steroids in bronchial asthma. comparison of the effects of inhaled beclomethasone and of oral prednisone on airway function, bronchial reactivity and hypothalamic-pituitary-adrenal axis. Eur Respir J 3 (1990) 786-791
30. Galon J., Franchimont D., Hiroi N., Frey G., Boettner A., Ehrhart-Bornstein M., et al. Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J 16 (2002) 61-71
31. Hsieh K.S., Weng K.P., Lin C.C., Huang T.C., Lee C.L., and Huang S.M. Treatment of acute Kawasaki disease. aspirin's role in the febrile stage revisited. Pediatrics 114 (2004) e689-e693